1
Feng Wei, Zhengliang Ye, Jun Gao, Chongnian Luo, Dekun Li, Jianming Chen, Yonghong Zhu, Junfeng Xiong, Xiaoli Zheng, Guangming Zhang, Ying Zhao: L., the compositions comprising said extracts, the preparing process and application thereof, Extracts of. Tasly Pharmaceutical Group, Evan Law Group, January 29, 2013: US08361515 (2 worldwide citation)

The present invention relates to plant extracts, specifically, the extracts of Chinese medicine Chenopodium ambrosioides L. and the composition comprising thereof. The extracts of Chinese medicine Chenopodium ambrosioides L. are prepared by conventional methods for the extraction of volatile oil, an ...


2
Yi Sun, Yonghong Zhu, Zhengbing Tong, Jie Wang: Method for extracting and separating ginkgolides. CHENGDU BAIYU TECHNOLOGY PHARMACY, Oliff, July 21, 2015: US09084755

A method for extracting and separating ginkgolides. The ginkgolides obtained through steps of extraction on a ginkgo leaf, further extraction, column chromatography, crystallization, and crystal mixing comprise 25.0% to 50.0% of bilobalide (C15H18O8), 20.0% to 45.0% of ginkgolide A (C20H24O9), 10.0% ...


3
Zhengliang Ye, Yonghong Zhu, Ying Zhao, Dekun Li, XiaoLi Zheng, Chongnian Luo, Feng Wei, GuangMing Zhang, JianMing Chen, Jun Gao, JunFeng Xiong: L., the compositions comprising said extracts, the preparing process and application thereof, Extracts of. Tasly Pharmaceutical Group, Evan Law Group, November 19, 2013: US08586108

The present invention relates to plant extracts, specifically, the extracts of Chinese medicine Chenopodium ambrosioides L. and the composition comprising thereof. The extracts of Chinese medicine Chenopodium ambrosioides L. are prepared by conventional methods for the extraction of volatile oil, an ...


4
Xiaolin Tong, Yonghong Zhu, Shuiping Zhou, Xiuhui E, Shuangming Wang, Zhongting Xia: Pharmaceutical composition for treating diabetes and its process for preparation. Tasly Pharmaceutical Group, Ladas & Parry, January 28, 2014: US08637092

The present invention relates to methods for preparing a pharmaceutical composition for treating diabetes mellitus and the pharmaceutical composition prepared by the methods. The pharmaceutical composition of the present invention comprises extracts of the following crude drugs: 5-40 weight parts of ...


5
Jianming Chen, Xijun Yan, Yuewu Yang, Wenliang Lu, Yonghong Zhu, Zhengliang Ye, Wei Wang, Guoguang Zhu, Zhigang Zheng, Shuangming Wang: Matrix adjuvants and the drop pills prepared with them. Tianjin Tasly Pharmaceutical China, Kaplan Gilman Gibson & Dernier, March 15, 2007: US20070059358-A1

The present invention relates to the matrix adjuvants for drop pills and the preparation of the drop pills. The matrix adjuvants for drop pills of the present invention comprise new matrix adjuvants with or without the plastifying components, which are typically natural matrix adjuvants derived from ...


6
Jianming Chen, Xijun Yan, Yonghong Zhu, Baoan Gao, Shunnan Zhang, Haiou Dong, Jizhong Zhang, Wei Li, Xinjiang Yan, Ying Zhao: Drop pill for treating coronary heart disease and preparation thereof. August 11, 2011: US20110195136-A1

The present invention relates to a drop pill for treating coronary heart disease, comprising an active pharmaceutical ingredient (API), a matrix adjuvant, a plastifying adjuvant, propylene glycol and water. the API is prepared from Radix salvia miltiorrhira, Panax notoginseng and Borneol; the matrix ...


7
Xiaolin Tong, Yonghong Zhu, Shuiping Zhou, Xiuhui E, Shuangming Wang, Zhongting Xia: Pharmaceutical composition for treating diabetes and its process for preparation. Tianjin Tasly Pharmaceutical, Ladas & Parry, June 3, 2010: US20100136150-A1

The present invention relates to methods for preparing a pharmaceutical composition for treating diabetes mellitus and the pharmaceutical composition prepared by the methods. The pharmaceutical composition of the present invention comprises extracts of the following crude drugs: 5-40 weight parts of ...


8
Yonghong Zhu: Prediction of hcv treatment response. Grant D Green, Patent Law Department, June 24, 2010: US20100158866-A1

The present invention is based on the discovery that in patients infected with Hepatitis C Virus Genotype 1 (HCV-1) or Genotype 4 (HCV-4), a beneficial response to a treatment that includes interferon alpha, ribavirin and a HCV polymerase inhibitor could be predicted if the patient's HCV RNA level b ...


9
Feng Wei, Zhengliang Ye, Ju Gao, Chongnian Luo, Dekun Li, Jiangming Chen, Yonghong Zhu, Junfeng Xiong, Xiaoli Zheng, Guangming Zhang, Ying Zhao: Extracts of chenopodium ambrosioides l., the compositions comprising said extracts, the preparing process and application thereof. Tianjin Tasly Pharmaceutical, Evan Law Group, May 21, 2009: US20090130203-A1

The present invention relates to plant extracts, specifically, the extracts of Chinese medicine Chenopodium ambrosioides L. and the composition comprising thereof. The extracts of Chinese medicine Chenopodium ambrosioides L. are prepared by conventional methods for the extraction of volatile oil, an ...


10
Shu Hui Chiu, Yonghong Zhu: Biomarkers for predicting rapid response to hcv treatment. Roche Molecular Systems, November 17, 2011: US20110281747-A1

The present invention is based on the discovery that in patients infected with Genotype 1 of the Hepatitis C virus (HCV-1) or Genotype 4 HCV (HCV-4) that undergo Triple Therapy treatment, certain biomarkers can be predictive of a patient achieving RVR2.